These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30864749)

  • 21. Cost Analysis of Tuberculosis Diagnosis in Cambodia with and without Xpert
    Pallas SW; Courey M; Hy C; Killam WP; Warren D; Moore B
    Appl Health Econ Health Policy; 2018 Aug; 16(4):537-548. PubMed ID: 29862440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rifampicin Resistance and Multidrug-Resistant Tuberculosis Detection Using Xpert MTB/RIF in Wuhan, China: A Retrospective Study.
    Huang H; Zhang Y; Li S; Wang J; Chen J; Pan Z; Gan H
    Microb Drug Resist; 2018 Jun; 24(5):675-679. PubMed ID: 29053085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tackling drug-resistant tuberculosis: we need a critical synergy of product and process innovations.
    Talbot EA; Pai M
    Int J Tuberc Lung Dis; 2019 Jul; 23(7):774-782. PubMed ID: 31439108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic performance of the Xpert MTB/RIF assay for tuberculous lymphadenitis on fine needle aspirates from Ethiopia.
    Biadglegne F; Mulu A; Rodloff AC; Sack U
    Tuberculosis (Edinb); 2014 Sep; 94(5):502-5. PubMed ID: 24931451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?
    Albert H; Nathavitharana RR; Isaacs C; Pai M; Denkinger CM; Boehme CC
    Eur Respir J; 2016 Aug; 48(2):516-25. PubMed ID: 27418550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China.
    Ou X; Xia H; Li Q; Pang Y; Wang S; Zhao B; Song Y; Zhou Y; Zheng Y; Zhang Z; Zhang Z; Li J; Dong H; Chi J; Zhang J; Kam KM; Huan S; Jun Y; Chin DP; Zhao Y
    Int J Infect Dis; 2015 Feb; 31():41-6. PubMed ID: 25447720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of Xpert® MTB/RIF technique for Mycobacterium tuberculosis complex detection in extra-respiratory specimens].
    García P; Balcells ME; Castillo C; Miranda C; Geoffroy E; Román JC; Wozniak A
    Rev Chilena Infectol; 2017 Aug; 34(4):333-339. PubMed ID: 29165509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of the Xpert MTB/RIF test on the time to MDR-TB treatment initiation in a rural setting: a cohort study in South Africa's Eastern Cape Province.
    Iruedo J; O'Mahony D; Mabunda S; Wright G; Cawe B
    BMC Infect Dis; 2017 Jan; 17(1):91. PubMed ID: 28109255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial screening of extra-pulmonary tuberculosis using the Xpert MTB/RIF assay improves case detection rates.
    Jain A; Singh PK; Singh U; Kumar V
    Int J Tuberc Lung Dis; 2017 Apr; 21(4):478-480. PubMed ID: 28284274
    [No Abstract]   [Full Text] [Related]  

  • 30. Genotype®MTBDRplus and Xpert®MTB/RIF in the diagnosis of tuberculosis and resistant tuberculosis: cost analysis in a tertiary referral hospital.
    Soares VM; Almeida IN; Vater MC; Alves S; Figueredo LJA; Scherer L; Kritski AL; Carvalho WDS; Miranda SS
    Rev Soc Bras Med Trop; 2020; 53():e20190175. PubMed ID: 32049199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Xpert MTB/RIF testing for rapid diagnosis of childhood pulmonary tuberculosis in children by Xpert MTB/RIF testing of stool samples in a low resource setting.
    Hasan Z; Shakoor S; Arif F; Mehnaz A; Akber A; Haider M; Kanji A; Hasan R
    BMC Res Notes; 2017 Sep; 10(1):473. PubMed ID: 28886729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reassessment of the positive predictive value and specificity of Xpert MTB/RIF: a diagnostic accuracy study in the context of community-wide screening for tuberculosis.
    Ho J; Nguyen PTB; Nguyen TA; Tran KH; Van Nguyen S; Nguyen NV; Nguyen HB; Luu KB; Fox GJ; Marks GB
    Lancet Infect Dis; 2016 Sep; 16(9):1045-1051. PubMed ID: 27289387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
    Hodille E; Maisson A; Charlet L; Bauduin C; Genestet C; Fredenucci I; Rasigade JP; Lina G; Dumitrescu O
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):601-605. PubMed ID: 30680567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis.
    Chang K; Lu W; Wang J; Zhang K; Jia S; Li F; Deng S; Chen M
    J Infect; 2012 Jun; 64(6):580-8. PubMed ID: 22381459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.
    Walusimbi S; Kwesiga B; Rodrigues R; Haile M; de Costa A; Bogg L; Katamba A
    BMC Health Serv Res; 2016 Oct; 16(1):563. PubMed ID: 27724908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient costs for the diagnosis of tuberculosis in Brazil: comparison of Xpert MTB/RIF and smear microscopy.
    da Silva Antunes R; Pinto M; Trajman A
    Int J Tuberc Lung Dis; 2014 May; 18(5):547-51. PubMed ID: 24903791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Xpert
    Beste J; Mutaquiha C; Manhiça I; Jose B; Monivo C; Faria M; Creswell J; Codlin AJ; Michel C; Wagenaar B; Gloyd S; Cowan J
    Int J Tuberc Lung Dis; 2018 Nov; 22(11):1358-1365. PubMed ID: 30355417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation validation performed in Rwanda to determine whether the INNO-LiPA Rif.TB line probe assay can be used for detection of multidrug-resistant Mycobacterium tuberculosis in low-resource countries.
    Quezada CM; Kamanzi E; Mukamutara J; De Rijk P; Rigouts L; Portaels F; Ben Amor Y
    J Clin Microbiol; 2007 Sep; 45(9):3111-4. PubMed ID: 17626172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study.
    van Kampen SC; Susanto NH; Simon S; Astiti SD; Chandra R; Burhan E; Farid MN; Chittenden K; Mustikawati DE; Alisjahbana B
    PLoS One; 2015; 10(6):e0123536. PubMed ID: 26075722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.